Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1

Infections caused by human immunodeficiency virus (HIV) are considered one of the main public health problems worldwide. Antiretroviral therapy (ART) is the current modality of treatment for HIV-1 infection. It comprises the combined use of several drugs and can decrease the viral load and increase...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria S. Serna-Arbeláez, Laura Florez-Sampedro, Lina P. Orozco, Katherin Ramírez, Elkin Galeano, Wildeman Zapata
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2021/5552088
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687036569583616
author Maria S. Serna-Arbeláez
Laura Florez-Sampedro
Lina P. Orozco
Katherin Ramírez
Elkin Galeano
Wildeman Zapata
author_facet Maria S. Serna-Arbeláez
Laura Florez-Sampedro
Lina P. Orozco
Katherin Ramírez
Elkin Galeano
Wildeman Zapata
author_sort Maria S. Serna-Arbeláez
collection DOAJ
description Infections caused by human immunodeficiency virus (HIV) are considered one of the main public health problems worldwide. Antiretroviral therapy (ART) is the current modality of treatment for HIV-1 infection. It comprises the combined use of several drugs and can decrease the viral load and increase the CD4+ T cell count in patients with HIV-1 infection, thereby proving to be an effective modality. This therapy significantly decreases the rate of morbidity and mortality owing to acquired immunodeficiency syndrome (AIDS) and prolongs and improves the quality of life of infected patients. However, nonadherence to ART may increase viral resistance to antiretroviral drugs and transmission of drug-resistant strains of HIV. Therefore, it is necessary to continue research for compounds with anti-HIV-1 activity, exhibiting a potential for the development of an alternative or complementary therapy to ART with low cost and fewer side effects. Natural products and their derivatives represent an excellent option owing to their therapeutic potential against HIV. Currently, the derivatives of natural products available as anti-HIV-1 agents include zidovudine, an arabinonucleoside derivative of the Caribbean marine sponge (Tectitethya crypta), which inhibits the reverse transcriptase of the virus. This was the first antiviral agent approved for treatment of HIV infection. Additionally, bevirimat (isolated from Syzygium claviflorum) and calanolide A (isolated from Calophyllum sp.) are inhibitors of viral maturation and reverse transcription process, respectively. In the present review, we aimed to describe the wide repertoire of natural compounds exhibiting anti-HIV-1 activity that can be considered for designing new therapeutic strategies to curb the HIV pandemic.
format Article
id doaj-art-020faac001b84eba87ee59b89e07d07a
institution DOAJ
issn 1687-8639
1687-8647
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Advances in Virology
spelling doaj-art-020faac001b84eba87ee59b89e07d07a2025-08-20T03:22:27ZengWileyAdvances in Virology1687-86391687-86472021-01-01202110.1155/2021/55520885552088Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1Maria S. Serna-Arbeláez0Laura Florez-Sampedro1Lina P. Orozco2Katherin Ramírez3Elkin Galeano4Wildeman Zapata5Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, ColombiaGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, ColombiaGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, ColombiaGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, ColombiaProductos Naturales Marinos, Departamento de Farmacia, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia (UdeA), Medellín, ColombiaGrupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, ColombiaInfections caused by human immunodeficiency virus (HIV) are considered one of the main public health problems worldwide. Antiretroviral therapy (ART) is the current modality of treatment for HIV-1 infection. It comprises the combined use of several drugs and can decrease the viral load and increase the CD4+ T cell count in patients with HIV-1 infection, thereby proving to be an effective modality. This therapy significantly decreases the rate of morbidity and mortality owing to acquired immunodeficiency syndrome (AIDS) and prolongs and improves the quality of life of infected patients. However, nonadherence to ART may increase viral resistance to antiretroviral drugs and transmission of drug-resistant strains of HIV. Therefore, it is necessary to continue research for compounds with anti-HIV-1 activity, exhibiting a potential for the development of an alternative or complementary therapy to ART with low cost and fewer side effects. Natural products and their derivatives represent an excellent option owing to their therapeutic potential against HIV. Currently, the derivatives of natural products available as anti-HIV-1 agents include zidovudine, an arabinonucleoside derivative of the Caribbean marine sponge (Tectitethya crypta), which inhibits the reverse transcriptase of the virus. This was the first antiviral agent approved for treatment of HIV infection. Additionally, bevirimat (isolated from Syzygium claviflorum) and calanolide A (isolated from Calophyllum sp.) are inhibitors of viral maturation and reverse transcription process, respectively. In the present review, we aimed to describe the wide repertoire of natural compounds exhibiting anti-HIV-1 activity that can be considered for designing new therapeutic strategies to curb the HIV pandemic.http://dx.doi.org/10.1155/2021/5552088
spellingShingle Maria S. Serna-Arbeláez
Laura Florez-Sampedro
Lina P. Orozco
Katherin Ramírez
Elkin Galeano
Wildeman Zapata
Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
Advances in Virology
title Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
title_full Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
title_fullStr Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
title_full_unstemmed Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
title_short Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
title_sort natural products with inhibitory activity against human immunodeficiency virus type 1
url http://dx.doi.org/10.1155/2021/5552088
work_keys_str_mv AT mariassernaarbelaez naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1
AT lauraflorezsampedro naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1
AT linaporozco naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1
AT katherinramirez naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1
AT elkingaleano naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1
AT wildemanzapata naturalproductswithinhibitoryactivityagainsthumanimmunodeficiencyvirustype1